Research in the Montagna Laboratory at the Rutgers Cancer Institute aims to understand the mechanisms by which genomic instability promotes tumor initiation and progression. Using advanced molecular cytogenetic approaches and single cell genomics methodologies applied to human and murine in culture and in vivo models we investigate the roles of large copy number alterations and papilloma virus insertional mutagenesis to tumor initiation and progression.
 |
Cristina Montagna, PhD Principle Investigator Professor of Radiation Oncology Division of Radiation Cancer Biology Co-leader, Genomic Instability and Cancer Genetics Rutgers Cancer Institute |
Dr. Cristina Montagna a cancer biologist with extensive expertise in molecular cytogenetic and cell biology. Her laboratory has contributed significant work to the field of oncogene discovery, genomic instability in cancer, and age-related tissue degeneration. She obtained her PhD from the University of Milano where she trained with Prof.
Investigators from Rutgers Cancer Institute, together with RWJBarnabas Health, found that a higher risk of mortality in Black breast cancer survivors is associated with a history of cigarette smoking along with regular alcohol consumption at the time of diagnosis. Learn more
Home | Research Accomplishments | Services & Requests | Equipment | Sample Preparation
In the 2018 – 2022 period, the IMFC SR supported approximately 110 publications of which 30 in high-Impact Factor Journals:
Home | Research Accomplishments | Services & Requests | Equipment
In the 2018 – 2022 period the MSR SR supported approximately 240 publications, of which 50 in high-Impact Factor Journals. The MSR’s high Impact Factor publications are shown below:
Home | Research Accomplishments | Services & Requests | Equipment
In the 2018 – 2022 period the CGSR supported approximately 30 cancer-relevant publications, eight of which in high Impact Factor journals (IF>10) and 13 unique peer-reviewed research grant awards (three funded by the NCI).
